Oliceridine
Burns
University of TennesseeSmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Burns cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ERGOCALCIFEROLUM University of North Carolina, Chapel Hill | Phase 2 | B |
FENTANYL Cephalon | Phase 2 | B |
TESTOSTERONE UNDECYLATE National Center for Research Resources (NCRR) | N/A | D |
Same molecule, other indications
Oliceridine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →